Chemical Composition and Analgesic and Antidiabetic Activity of Chenopodium ambrosioides L
Cell Biochemistry and Function · 2024
DOI: 10.1002/cbf.70016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Soufiane Drioua und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical Chemistry and Food Science, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Analgesics, Plant Extracts, Chenopodium ambrosioides. Die Arbeit nennt 26 Literaturangaben. Gefördert von: This study was supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2023R33)..
Abstract (Originalsprache)
This study focuses on identifying active compounds within Chenopodium ambrosioides extracts and fractions, with a specific emphasis on their potential analgesic and antidiabetic properties. The motivation arises from the reported therapeutic effects of the plant and the desire to pinpoint the compounds responsible for these benefits. Gas chromatography–mass spectrometry spectrophotometric analysis was employed to characterize chemical constituents in the aqueous extracts (infused aqueous extract and macerated aqueous extract) and fractions (cyclohexane fraction, ethyl acetate fraction, butanol fraction, remaining aqueous fraction) of C. ambrosioides . Animal models were used to examine the analgesic activity, while α‐glucosidase and α‐amylase enzyme assays were used to investigate the antidiabetic effect. Throughout the investigation, several chemical families were found, including phenolic compounds, alcohols, acids, terpenes, steroids, and others. Trans‐ascaridol glycol, palmitic acid, phenol, octadecadienoic acid, isoascaridol, eicosanoic acid, 2‐methoxy‐4‐vinyl phenol, mexiletine, and thymol were among the significant chemicals found. At a dose of 500 mg/m, starting with α‐amylase inhibition, among the extracts, EAF (59 ± 0.7 μg/mL) showed the highest potency, followed by FA (129 ± 0.22 μg/mL), FB (140 ± 0.9 μg/mL), and EAM (178 ± 0.9 μg/mL). Interestingly, EAI demonstrated a relatively weak inhibition (430 ± 0.2 μg/mL), and no result was reported for FCH in this category. Regarding α‐glucosidase inhibition, the most potent activity was observed with EAM (1.4 ± 0.7 μg/mL), The other extracts demonstrated varying levels of inhibition, with EAI (4.4 ± 0.5 μg/mL) and EAF (140 ± 1.9 μg/mL) showing moderate activity. FA (25 ± 0.9 μg/mL) and FB (34 ± 0.3 μg/mL) exhibited lower inhibition compared to EAM but still outperformed acarbose in this test. The observed synergistic effects of phenolic compounds in Chenopodium ambrosioides provide insights into the biological properties contributing to its reported analgesic and antidiabetic effects. The study underscores the potential of natural plant products for pharmaceutical applications, especially in enzymatic inhibition. All things considered, these results add to the expanding corpus of information about substances originating from plants and their uses in industry and health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Analytical Chemistry and Food Science, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
- Laboratory of Pharmacology and Toxicology, Biopharmaceutical and Toxicological Analysis Research Team, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco.
- Green Biotechnology Laboratory, Moroccan Foundation for Advanced Science, Innovation and Research (MAScIR), Rabat Design Centre, Rabat, Morocco.
- Laboratory of Health Sciences and Technologies, High Institute of Health Sciences, Hassan 1st University, Settat, Morocco.
- Department of Drug Sciences Laboratory of Medicinal Chemistry, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
- Medicinal Aromatic and Poisonous Plants Research Center, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Förderung
- This study was supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2023R33).
Zitieren
APA
Drioua, S., Ameggouz, M., Laabar, A., Aasfar, A., Faouzi, M. E. A., Zahidi, A., Ullah, R., Alotaibi, A., Bouyahya, A., Zengin, G., Balahbib, A., Benzied, H., & Doukkali, A. (2024). Chemical Composition and Analgesic and Antidiabetic Activity of Chenopodium ambrosioides L. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70016
Vancouver
Drioua S, Ameggouz M, Laabar A, Aasfar A, Faouzi MEA, Zahidi A, et al. Chemical Composition and Analgesic and Antidiabetic Activity of Chenopodium ambrosioides L. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.70016
BibTeX
@article{Drioua2024,
author = {Drioua, Soufiane and Ameggouz, Mouna and Laabar, Abdelmounaim and Aasfar, Abderrahim and Faouzi, Moulay El Abbes and Zahidi, Ahmed and Ullah, Riaz and Alotaibi, Amal and Bouyahya, Abdelhakim and Zengin, Gokhan and Balahbib, Abdelaali and Benzied, Hanane and Doukkali, Anass},
title = {Chemical Composition and Analgesic and Antidiabetic Activity of Chenopodium ambrosioides L},
journal = {Cell Biochemistry and Function},
year = {2024},
doi = {10.1002/cbf.70016}
}
EUVIMED